Correlation Between AbbVie and Hyperfine
Can any of the company-specific risk be diversified away by investing in both AbbVie and Hyperfine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Hyperfine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Hyperfine, you can compare the effects of market volatilities on AbbVie and Hyperfine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Hyperfine. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Hyperfine.
Diversification Opportunities for AbbVie and Hyperfine
Weak diversification
The 3 months correlation between AbbVie and Hyperfine is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Hyperfine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hyperfine and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Hyperfine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hyperfine has no effect on the direction of AbbVie i.e., AbbVie and Hyperfine go up and down completely randomly.
Pair Corralation between AbbVie and Hyperfine
Given the investment horizon of 90 days AbbVie Inc is expected to under-perform the Hyperfine. But the stock apears to be less risky and, when comparing its historical volatility, AbbVie Inc is 1.66 times less risky than Hyperfine. The stock trades about -0.06 of its potential returns per unit of risk. The Hyperfine is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 99.00 in Hyperfine on October 25, 2024 and sell it today you would lose (6.00) from holding Hyperfine or give up 6.06% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
AbbVie Inc vs. Hyperfine
Performance |
Timeline |
AbbVie Inc |
Hyperfine |
AbbVie and Hyperfine Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AbbVie and Hyperfine
The main advantage of trading using opposite AbbVie and Hyperfine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Hyperfine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hyperfine will offset losses from the drop in Hyperfine's long position.AbbVie vs. Merck Company | AbbVie vs. Pfizer Inc | AbbVie vs. Eli Lilly and | AbbVie vs. Bristol Myers Squibb |
Hyperfine vs. Neuropace | Hyperfine vs. Orthopediatrics Corp | Hyperfine vs. Anika Therapeutics | Hyperfine vs. PAVmed Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
CEOs Directory Screen CEOs from public companies around the world | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |